PA
BIVV

Profund Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Profund Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-51,133
Closed -$2.76M – 1523
2017
Q4 		$2.76M Sell
51,133
-5,189
-9% -$284K 0.11% 160
2017
Q3 		$3.21M Buy
56,322
+4,861
+9% +$285K 0.13% 131
2017
Q2 		$3.1M Sell
51,461
-6,395
-11% -$364K 0.14% 119
2017
Q1 		$3.15M Buy
+57,856
New +$2.85M 0.14% 116

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Profund Advisors's BIVV Position: Q1 2018 in Review

Profund Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 51,133 shares — an estimated $2.76M sold.

Profund Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $3.21M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Profund Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Profund Advisors sold 51,133 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2.76M.
  • Profund Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Profund Advisors's Bioverativ Inc. Common Stock position peaked at $3.21M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Profund Advisors's 13F filing for Q1 2018, filed 14 May 2018.